These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 16265257

  • 21. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies.
    Nienaber CA, Eagle KA.
    Circulation; 2003 Aug 05; 108(5):628-35. PubMed ID: 12900496
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events.
    Ramirez F, Dietz HC.
    J Cell Physiol; 2007 Nov 05; 213(2):326-30. PubMed ID: 17708531
    [Abstract] [Full Text] [Related]

  • 25. Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome.
    Fleischer KJ, Nousari HC, Anhalt GJ, Stone CD, Laschinger JC.
    Ann Thorac Surg; 1997 Apr 05; 63(4):1012-7. PubMed ID: 9124898
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Recent progress towards a molecular understanding of Marfan syndrome.
    Dietz HC, Loeys B, Carta L, Ramirez F.
    Am J Med Genet C Semin Med Genet; 2005 Nov 15; 139C(1):4-9. PubMed ID: 16273535
    [Abstract] [Full Text] [Related]

  • 28. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation and systemic sclerosis.
    Lemaire R, Bayle J, Lafyatis R.
    Curr Opin Rheumatol; 2006 Nov 15; 18(6):582-7. PubMed ID: 17053502
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Coexistent Marfan's syndrome and ankylosing spondylitis.
    Kiss C, Jónap I, Gergely P, Poór G.
    J Rheumatol; 2006 Jun 15; 33(6):1199-200. PubMed ID: 16755670
    [Abstract] [Full Text] [Related]

  • 33. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
    Guo G, Muñoz-García B, Ott CE, Grünhagen J, Mousa SA, Pletschacher A, von Kodolitsch Y, Knaus P, Robinson PN.
    Hum Mol Genet; 2013 Feb 01; 22(3):433-43. PubMed ID: 23100322
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR, Clayton NP, Carta L, Galatioto J, Chiu E, Smaldone S, Nelson CA, Cheng SH, Wentworth BM, Ramirez F.
    Arterioscler Thromb Vasc Biol; 2015 Apr 01; 35(4):911-7. PubMed ID: 25614286
    [Abstract] [Full Text] [Related]

  • 36. Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells.
    Quarto N, Li S, Renda A, Longaker MT.
    Stem Cells; 2012 Dec 01; 30(12):2709-19. PubMed ID: 23037987
    [Abstract] [Full Text] [Related]

  • 37. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome.
    Crosas-Molist E, Meirelles T, López-Luque J, Serra-Peinado C, Selva J, Caja L, Gorbenko Del Blanco D, Uriarte JJ, Bertran E, Mendizábal Y, Hernández V, García-Calero C, Busnadiego O, Condom E, Toral D, Castellà M, Forteza A, Navajas D, Sarri E, Rodríguez-Pascual F, Dietz HC, Fabregat I, Egea G.
    Arterioscler Thromb Vasc Biol; 2015 Apr 01; 35(4):960-72. PubMed ID: 25593132
    [Abstract] [Full Text] [Related]

  • 38. Molecular pathogenesis of Marfan syndrome.
    Ramachandra CJ, Mehta A, Guo KW, Wong P, Tan JL, Shim W.
    Int J Cardiol; 2015 Apr 01; 187():585-91. PubMed ID: 25863307
    [Abstract] [Full Text] [Related]

  • 39. [Novel pharmacological strategies for aortic dilation in Marfan syndrome: from mouse models to human patients].
    Perrino C, Schiattarella GG, Bottino R, Magliulo F, Oliveti M, Esposito G, Trimarco B.
    G Ital Cardiol (Rome); 2014 Apr 01; 15(7-8):408-17. PubMed ID: 25174594
    [Abstract] [Full Text] [Related]

  • 40. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
    Emrich FC, Okamura H, Dalal AR, Penov K, Merk DR, Raaz U, Hennigs JK, Chin JT, Miller MO, Pedroza AJ, Craig JK, Koyano TK, Blankenberg FG, Connolly AJ, Mohr FW, Alvira CM, Rabinovitch M, Fischbein MP.
    Arterioscler Thromb Vasc Biol; 2015 Jan 01; 35(1):146-54. PubMed ID: 25359856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.